Equities / Sectors / Healthcare
Healthcare
#6 by market capPharmaceuticals, biotechnology, medical devices and care providers. 564 US-listed equities across 10 industries; the sector accounts for 9.2% of tracked equity market cap and 10.8% of daily volume.
Market cap
$7.68T
-0.63%
-$48.574B · 1D
Sector weight
9.2%
of tracked market cap
Volume 24h
$67.171B
10.8% of market volume
Revenue TTM
$4.184T
Sum of constituents
Net income TTM
$153.576B
3.7% net margin
P/E (TTM)
49.7×
Market 30.7×
Dividend yield
1.8%
Market 1.3%
Employees
4.4M
Across 564 companies
Industry breakdown
Share of sector market cap · 10 industries
Concentration
Share of sector market cap by constituent
HHI index
391.6
Mega caps
7
Median cap
$1.391B
Valuation vs. market
Sector totals valued as one company; marker is the all-equities median
P/E (TTM): 49.7× · market 20.2×
P/S: 1.8× · market 2.7×
EV / EBITDA: 19.2× · market 13×
Operating margin: 7.9% · market 8.5%
Dividend yield: 1.8% · market 2.3%
Trading at a 62.1% P/E premium to the all-equities market.
Returns vs. market
Cap-weighted price return · spread in percentage points
| Period | Sector | Market | Spread |
|---|---|---|---|
| 1 day | -0.63% | +0.54% | -1.17% |
| 1 week | -2.52% | +2.05% | -4.58% |
| 1 month | -0.66% | +1.46% | -2.12% |
| 3 months | +0.34% | +3.30% | -2.95% |
| Year to date | +8.61% | +13.25% | -4.64% |
| 1 year | +17.03% | +14.81% | +2.22% |
Constituents
564 equities
Eli Lilly and Company LLY · US | Drug Manufacturers - General | $1.032T | 13.4% | $1.16K | +1.26% | -2.30% | +2.99% | $2.467B | 38.6× |
Johnson & Johnson JNJ · US | Drug Manufacturers - General | $613.568B | 8% | $254.78 | +0.73% | -6.31% | -5.33% | $1.442B | 29.2× |
AbbVie Inc. ABBV · US | Drug Manufacturers - General | $471.26B | 6.1% | $266.69 | +0.35% | +0.15% | +7.20% | $1.2B | 75.2× |
Merck & Co., Inc. MRK · US | Drug Manufacturers - General | $350.548B | 4.6% | $141.94 | +1.72% | -4.54% | -4.39% | $1.146B | 39.2× |
UnitedHealth Group Inc. UNH · US | Healthcare Plans | $340.57B | 4.4% | $376.32 | -0.60% | -0.40% | -6.12% | $1.896B | 24.1× |
Thermo Fisher Scientific Inc. TMO · US | Diagnostics & Research | $243.999B | 3.2% | $656.58 | -2.98% | -3.25% | +8.88% | $1.804B | 35.6× |
Amgen Inc. Common Stock AMGN · US | Drug Manufacturers - General | $217.646B | 2.8% | $402.60 | -0.09% | -3.71% | +2.40% | $819.89M | 24.9× |
Gilead Sciences, Inc. GILD · US | Drug Manufacturers - General | $178.989B | 2.3% | $144.23 | -0.28% | -5.24% | -1.64% | $537.03M | -55.2× |
Abbott Laboratories ABT · US | Medical Devices | $170.976B | 2.2% | $98.16 | -1.94% | -2.79% | -6.98% | $1.038B | 27.2× |
Pfizer Inc. PFE · US | Drug Manufacturers - General | $156.723B | 2% | $27.50 | +0.33% | -4.25% | -1.04% | $661.12M | 20.9× |
Danaher Corp. DHR · US | Diagnostics & Research | $151.552B | 2% | $215.61 | -2.53% | -5.16% | +5.06% | $785.38M | 37.9× |
Intuitive Surgical Inc. ISRG · US | Medical Instruments & Supplies | $143.245B | 1.9% | $404.76 | -0.42% | -2.42% | +15.59% | $667.73M | 45.6× |
| Biotechnology | $127.259B | 1.7% | $502.31 | -0.24% | -4.81% | -5.03% | $389.29M | 28.9× | |
Bristol-Myers Squibb Company BMY · US | Drug Manufacturers - General | $121.667B | 1.6% | $59.59 | +1.33% | -6.72% | -7.88% | $589.07M | 13.1× |
Medtronic plc MDT · US | Medical Devices | $111.479B | 1.5% | $87.09 | -1.00% | -2.69% | -5.74% | $4.54B | 21.3× |
McKesson Corporation MCK · US | Medical Distribution | $110.6B | 1.4% | $921.67 | +0.68% | +7.64% | +3.66% | $627.2M | 23.2× |
CVS Health Corporation Common Stock CVS · US | Healthcare Plans | $110.458B | 1.4% | $86.43 | -0.67% | -1.62% | -10.03% | $952.8M | 22.6× |
Stryker Corp. SYK · US | Medical Devices | $106.71B | 1.4% | $278.20 | -2.46% | +1.05% | +0.64% | $794.54M | 28.6× |
HCA Healthcare, Inc. HCA · US | Medical Care Facilities | $94.204B | 1.2% | $432.20 | -0.63% | -0.09% | +7.51% | $431.85M | 13.8× |
Elevance Health, Inc. ELV · US | Healthcare Plans | $86.967B | 1.1% | $400.09 | +1.41% | +1.39% | -0.46% | $492.19M | 16.6× |
Regeneron Pharmaceuticals, Inc. REGN · US | Biotechnology | $77.578B | 1% | $738.72 | +1.69% | -1.80% | -8.84% | $454.39M | 17.5× |
Moderna Inc. MRNA · US | Biotechnology | $74.797B | 1% | $187.46 | -7.75% | -4.98% | +33.59% | $3.519B | -23.7× |
The Cigna Group CI · US | Healthcare Plans | $72.333B | 0.9% | $274.37 | +1.14% | +0.93% | -0.53% | $300M | 11.3× |
Boston Scientific Corp. BSX · US | Medical Devices | $61.037B | 0.8% | $42.19 | -0.50% | -4.35% | -6.20% | $529.3M | 16.6× |
Cencora Inc. COR · US | Medical Distribution | $60.372B | 0.8% | $316.37 | +0.46% | +4.13% | -2.56% | $258.76M | 23× |